澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - buprenorphine, quantity: 10 mg - drug delivery system, transdermal - excipient ingredients: povidone; polyethylene; levulinic acid; oleyl oleate; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; butyl acrylate; acrylic acid; 2,2'-azobisisobutyronitrile; aluminium acetylacetonate; heptane; acrylates copolymer; ethylene distearamide; adipic acid/1,4-butanediol/mdi copolymer; pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate - buprenorphine sandoz patches are indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. buprenorphine sandoz patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. buprenorphine sandoz patches are not indicated as an as-needed (prn) analgesia.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - entecavir, quantity: 0.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate; crospovidone; hypromellose; titanium dioxide; purified talc; macrogol 6000 - entecavir sandoz is indicated for the treatment of chronic hepatitis b virus infection in adults 16 years or older with evidence of active liver inflammation. this indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment naive and lamividine-resistant adult patients with hbeag-positive or hbeag-negative chronic hbv infection with compensated liver disease.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - entecavir, quantity: 1 mg - tablet, film coated - excipient ingredients: purified talc; hypromellose; titanium dioxide; lactose monohydrate; crospovidone; magnesium stearate; microcrystalline cellulose; macrogol 6000; iron oxide red; iron oxide yellow - entecavir sandoz is indicated for the treatment of chronic hepatitis b virus infection in adults 16 years or older with evidence of active liver inflammation. this indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment naive and lamividine-resistant adult patients with hbeag-positive or hbeag-negative chronic hbv infection with compensated liver disease.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: magnesium stearate; hypromellose; purified water; microcrystalline cellulose; hyprolose; lactose monohydrate; titanium dioxide; iron oxide yellow; macrogol 4000 - olmesartan sandoz is indicated for the treatment of hypertension.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: hypromellose; microcrystalline cellulose; lactose monohydrate; hyprolose; purified water; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 4000 - olmesartan sandoz is indicated for the treatment of hypertension.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - pregabalin, quantity: 300 mg - capsule - excipient ingredients: maize starch; iron oxide yellow; iron oxide black; purified talc; iron oxide red; titanium dioxide; gelatin; pregelatinised maize starch - pregabalin sandoz is indicated for the treatment of neuropathic pain in adults. pregabalin sandoz is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - pregabalin, quantity: 25 mg - capsule - excipient ingredients: iron oxide red; iron oxide yellow; titanium dioxide; gelatin; iron oxide black; maize starch; pregelatinised maize starch; purified talc - pregabalin sandoz is indicated for the treatment of neuropathic pain in adults. pregabalin sandoz is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - pregabalin, quantity: 150 mg - capsule - excipient ingredients: maize starch; gelatin; titanium dioxide; pregelatinised maize starch; purified talc - pregabalin sandoz is indicated for the treatment of neuropathic pain in adults. pregabalin sandoz is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - pregabalin, quantity: 75 mg - capsule - excipient ingredients: pregelatinised maize starch; iron oxide red; gelatin; titanium dioxide; purified talc; iron oxide yellow; maize starch - pregabalin sandoz is indicated for the treatment of neuropathic pain in adults. pregabalin sandoz is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - voriconazole, quantity: 50 mg - tablet, film coated - excipient ingredients: povidone; croscarmellose sodium; lactose monohydrate; magnesium stearate; pregelatinised maize starch; titanium dioxide; hypromellose; triacetin - voriconazole sandoz is indicated for treatment of the following fungal infections:,- invasive aspergillosis.,- serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,- serious fungal infections caused by scedosporium spp and fusarium spp.,- other serious fungal infections, in patients intolerant of, or refractory to, other therapy,- prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.,- this brand is only available as tablets and therefore only indicated for adults and children 12 years or older who can tolerate tablets. for dosing requirements for populations who require intravenous or oral suspension treatment see dosage and administration.